Article(id=1330183699066368692, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183658524225975, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.03.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1660060800000, receivedDateStr=2022-08-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070107474, onlineDateStr=2026-11-19, pubDate=1678377600000, pubDateStr=2023-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070107474, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070107474, creator=13701087609, updateTime=1795070107474, updator=13701087609, issue=Issue{id=1330183658524225975, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='3', pageStart='295', pageEnd='469', issueExtLink='null', onlineDate='null', pubDate='1678377600000', pubDateStr='2023-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070097809, creator='13701087609', updateTime=1795080445872, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227062121541875, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183658524225975, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227062121541876, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330183658524225975, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=304, endPage=311, ext={EN=ArticleExt(id=1330183699385135797, articleId=1330183699066368692, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Development and Challenges for Nucleic Acid Modifications and Delivery Systems of mRNA Vaccines, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

mRNA vaccines have attracted extensive attention from academia, industry, and regulatory agencies for their development flexibility and high immunogenicity. They have been widely used to prevent and control the Corona Virus Disease 2019(COVID-19). While mRNA vaccines have a low risk of recombination and good safety, their poor stability and strict storage and transportation conditions limit their applications. Nucleic acid modifications and novel delivery systems have been used to improve the stability of mRNA vaccines and enhance their safety and efficacy. From the perspective of the molecular basis and formulation development of mRNA vaccines, the development status and critical technologies of mRNA vaccines are reviewed, and the challenges and possible solutions of mRNA vaccines in the development and application are discussed.

, authors=Wenbin DONG1, Xuemei ZHANG1, *, Yifei CHEN2, *, authorsList=Wenbin DONG, Xuemei ZHANG, Yifei CHEN, authorCompany=null, correspAuthors=Xuemei ZHANG, Yifei CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330183699695514295, articleId=1330183699066368692, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=mRNA疫苗核酸修饰与递送系统的发展历程与挑战, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

mRNA疫苗因其开发灵活性、高免疫原性而受到学术界、产业界和监管方等的广泛关注,在2019新型冠状病毒病(corona virus disease 2019,COVID-19)的疫情防控中得到了广泛应用。mRNA疫苗的基因重组风险低、安全性好,但稳定性较差,贮存和运输较困难。可采用核酸修饰和新型递送系统以改善mRNA疫苗的稳定性,增强其安全性和有效性。该文从mRNA疫苗的分子学基础与制剂开发角度,介绍了mRNA疫苗的发展现状及其关键技术,并讨论了mRNA疫苗在研发和应用中的难点和可能的解决方向。

, authors=董文彬1, 张雪梅1, *, 陈一飞2, *, authorsList=董文彬, 张雪梅, 陈一飞, authorCompany=null, correspAuthors=张雪梅, 陈一飞, authorNote=

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

, correspAuthorsNote=
陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学研究。E-mail:
张雪梅(1971—),女,教授,从事药学、药理学相关研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=49X0nnduI6GLK3Glw4TNDw==, magXml=yGM7SKZ4hZyQ10oi6KjZCA==, pdfUrl=null, pdf=MIlfp/AEjU7nnSG0tvZDiQ==, pdfFileSize=2089762, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=JBIOc7zw/bve96avdSHypw==, mapNumber=null, fund=null)}, authors=[Author(id=1330183700047835839, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183700131721921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700047835839, language=EN, stringName=Wenbin DONG, firstName=Wenbin, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183700215608002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700047835839, language=CN, stringName=董文彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学药学院,上海 201203, bio={"content":"

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

"}, bioImg=null, bioContent=

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699863286456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=1., ext=[AuthorCompanyExt(id=1330183699867480761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330183699880063674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1330183700303688388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuemzhang@fudan.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183700391768774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700303688388, language=EN, stringName=Xuemei ZHANG, firstName=Xuemei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183702010770123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700303688388, language=CN, stringName=张雪梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699863286456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=1., ext=[AuthorCompanyExt(id=1330183699867480761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330183699880063674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1330183702128210637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenyifei25@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183702233068239, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183702128210637, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183702325342928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183702128210637, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699947172539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=2., ext=[AuthorCompanyExt(id=1330183699955561148, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330183699963949757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1330183702455366353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=EN, orderNo=1, keyword=mRNA vaccine), Keyword(id=1330183702577001170, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=EN, orderNo=2, keyword=nucleic acid modification), Keyword(id=1330183702681858771, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=EN, orderNo=3, keyword=delivery system), Keyword(id=1330183702769939156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=CN, orderNo=1, keyword=mRNA疫苗), Keyword(id=1330183702845436629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=CN, orderNo=2, keyword=核酸修饰), Keyword(id=1330183702925128407, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, language=CN, orderNo=3, keyword=递送系统)], refs=[Reference(id=1330183703034180312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CREECH C B, WALKER S C, SAMUELS R J. SARS-CoV-2 Vaccines [J]. JAMA, 2021, 325(13): 1318-1320., articleTitle=null, refAbstract=null), Reference(id=1330183703113872089, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=杭辰悦,徐山杉,吴其峰,等.mRNA 治疗及其应用前景[J].科学通报,2021,66(Z2):3649-3666., articleTitle=null, refAbstract=null), Reference(id=1330183703185175258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=GHATTAS M, DWIVEDI G, LAVERTU M, et al. Vaccine technologies and platforms for infectious diseases:current progress, challenges, and opportunities [J]. Vaccines(Basel), 2021, 9(12): 1490., articleTitle=null, refAbstract=null), Reference(id=1330183703252284123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=叶瑞贤,张锡宝.疫苗的发展历史[J].皮肤科学通报,2020,37(4):329-335., articleTitle=null, refAbstract=null), Reference(id=1330183703348753116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM J, EYGERIS Y, GUPTA M, SAHAY G, et al. Self-assembled mRNA vaccines [J]. Adv Drug Deliv Rev, 2021,170: 83-112., articleTitle=null, refAbstract=null), Reference(id=1330183703449416413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MINNAERT A K, VANLUCHENE H, VERBEKE R, et al. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across [J]. Adv Drug Deliv Rev, 2021, 176:113900., articleTitle=null, refAbstract=null), Reference(id=1330183703596217054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LI C, LEE A, GRIGORYAN L, et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine [J]. Nat Immunol, 2022, 23(4): 543-555., articleTitle=null, refAbstract=null), Reference(id=1330183703671714527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=井汇源,段二珍,董望.体外转录的自我复制型mRNA疫苗研究进展[J].中国生物工程杂志,2020,40(12):25-30., articleTitle=null, refAbstract=null), Reference(id=1330183703751406304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=BEISSERT T, PERKOVIC M, VOGEL A, et al. A trans-amplifying RNA vaccine strategy for induction of potent protective immunity [J]. Mol Ther, 2020, 28(1): 119-128., articleTitle=null, refAbstract=null), Reference(id=1330183703856263907, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAUDHARY N, WEISSMAN D, WHITEHEAD K A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation [J]. Nat Rev Drug Discov, 2021,20(11): 817-838., articleTitle=null, refAbstract=null), Reference(id=1330183703969510116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, ZHANG Z Q, LUO J W, et al. mRNA vaccine:a potential therapeutic strategy [J]. Mol Cancer, 2021,20(1): 33., articleTitle=null, refAbstract=null), Reference(id=1330183704053396197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LINARES-FERNÁNDEZ S, LACROIX C, EXPOSITO J Y, et al. Tailoring mRNA vaccine to balance innate/adaptive immune response [J]. Trends Mol Med, 2020, 26(3): 311-323., articleTitle=null, refAbstract=null), Reference(id=1330183704137282278, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=DOLGIN E. The tangled history of mRNA vaccines [J]. Nature, 2021, 597(7876): 318-324., articleTitle=null, refAbstract=null), Reference(id=1330183704216974055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KRIEG P A, MELTON D A. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs[J]. Nucleic Acids Res, 1984, 12(18): 7057-7070., articleTitle=null, refAbstract=null), Reference(id=1330183704317637352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=JIRIKOWSKI G F, SANNA P P, MACIEJEWSKI-LENOIR D, et al. Reversal of diabetes insipidus in Brattleboro rats:intrahypothalamic injection of vasopressin mRNA [J]. Science, 1992, 255(5047): 996-998., articleTitle=null, refAbstract=null), Reference(id=1330183704401523435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=KARIKÓ K, BUCKSTEIN M, NI H, et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA[J]. Immunity, 2005, 23(2): 165-175., articleTitle=null, refAbstract=null), Reference(id=1330183704481215212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=JIA L F, QIAN S B. Therapeutic mRNA engineering from head to tail [J]. Acc Chem Res, 2021, 54(23): 4272-4282., articleTitle=null, refAbstract=null), Reference(id=1330183704539935469, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=田颖,张娜娜,秦成峰,等.mRNA技术应对病毒传染病的研究进展[J].微生物学通报,2022,49(7):2849-2861., articleTitle=null, refAbstract=null), Reference(id=1330183704640598766, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WALCZAK S, NOWICKA A, KUBACKA D, et al. A novel route for preparing 5' cap mimics and capped RNAs:phosphate-modified cap analogues obtained via click chemistry [J]. Chem Sci, 2017, 8(1): 260-267., articleTitle=null, refAbstract=null), Reference(id=1330183704716096239, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=PASSMORE L A, COLLER J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression [J]. Nat Rev Mol Cell Biol, 2022, 23(2): 93-106., articleTitle=null, refAbstract=null), Reference(id=1330183704820953840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=LIMA S A, CHIPMAN L B, NICHOLSON A L, et al. Short poly(A) tails are a conserved feature of highly expressed genes [J]. Nat Struct Mol Biol, 2017, 24(12): 1057-1063., articleTitle=null, refAbstract=null), Reference(id=1330183704913228531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LEPPEK K, DAS R, BARNA M. Functional 5' UTR mRNA structures in eukaryotic translation regulation and how to find them [J]. Nat Rev Mol Cell Biol, 2018, 19(3): 158-174., articleTitle=null, refAbstract=null), Reference(id=1330183706549007092, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=MAYR C. Regulation by 3'-untranslated regions [J]. Annu Rev Genet, 2017, 51: 171-194., articleTitle=null, refAbstract=null), Reference(id=1330183706628698869, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=JEFFS L B, PALMER L R, AMBEGIA E G, et al. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA [J]. Pharm Res, 2005,22(3): 362-372., articleTitle=null, refAbstract=null), Reference(id=1330183706725167862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=GEALL A J, VERMA A, OTTEN G R, et al. Nonviral delivery of self-amplifying RNA vaccines [J]. Proc Natl Acad Sci U S A, 2012, 109(36): 14604-14609., articleTitle=null, refAbstract=null), Reference(id=1330183706842608375, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=CULLIS P R, HOPE M J. Lipid nanoparticle systems for enabling gene therapies [J]. Mol Ther, 2017, 25(7): 1467-1475., articleTitle=null, refAbstract=null), Reference(id=1330183706943271672, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=JARZEBSKA N T, MELLETT M, FREI J, et al. Protamine-based strategies for RNA transfection [J]. Pharmaceutics,2021, 13(6): 877., articleTitle=null, refAbstract=null), Reference(id=1330183707018769145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=KREMSNER P G, AHUAD GUERRERO R A, ARANA-ARRI E, et al. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America(HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial [J]. Lancet Infect Dis, 2022, 22(3): 329-340., articleTitle=null, refAbstract=null), Reference(id=1330183707102655226, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=KOWALSKI P S, RUDRA A, MIAO L, et al. Delivering the messenger: advances in technologies for therapeutic mRNA delivery [J]. Mol Ther, 2019, 27(4): 710-728., articleTitle=null, refAbstract=null), Reference(id=1330183707190735611, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=REN J, CAO Y M, LI L, et al. Self-assembled polymeric micelle as a novel mRNA delivery carrier [J]. J Control Release, 2021, 338: 537-547., articleTitle=null, refAbstract=null), Reference(id=1330183707262038780, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=SAMARIDOU E, HEYES J, LUTWYCHE P. Lipid nanoparticles for nucleic acid delivery: current perspectives[J]. Adv Drug Deliv Rev, 2020, 154-155: 37-63., articleTitle=null, refAbstract=null), Reference(id=1330183707329147645, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=RUSESKA I, FRESACHER K, PETSCHACHER C, et al. Use of protamine in nanopharmaceuticals-a review [J]. Nanomaterials(Basel), 2021, 11(6): 1508., articleTitle=null, refAbstract=null), Reference(id=1330183707442393854, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=PUTNAM D. Polymers for gene delivery across length scales [J]. Nat Mater, 2006, 5(6): 439-451., articleTitle=null, refAbstract=null), Reference(id=1330183707601777407, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=PARHIZ H, BRENNER J S, PATEL P N, et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation(IE)[J]. J Control Release,2022, 344: 50-61., articleTitle=null, refAbstract=null), Reference(id=1330183707727606528, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MU X, HUR S. Immunogenicity of in vitro-transcribed RNA [J]. Acc Chem Res, 2021, 54(21): 4012-4023., articleTitle=null, refAbstract=null), Reference(id=1330183707849241345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHONG Z F, MCCAFFERTY S, OPSOMER L, et al. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs [J]. Mol Ther, 2021, 29(4): 1370-1381., articleTitle=null, refAbstract=null), Reference(id=1330183707924738818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=BAIERSDÖRFER M, BOROS G, MURAMATSU H, et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA [J]. Mol Ther Nucleic Acids,2019, 15: 26-35., articleTitle=null, refAbstract=null), Reference(id=1330183708025402115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=WU M Z, ASAHARA H, TZERTZINIS G, et al. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription [J]. RNA, 2020, 26(3): 345-360., articleTitle=null, refAbstract=null), Reference(id=1330183708147036932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO H, WANG T C, LI X F, et al. Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates [J]. Signal Transduct Target Ther, 2021, 6(1): 438., articleTitle=null, refAbstract=null), Reference(id=1330183708218340101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=STITZ L, VOGEL A, SCHNEE M, et al. A thermostable messenger RNA based vaccine against rabies [J]. PLoS Negl Trop Dis, 2017, 11(12): e0006108., articleTitle=null, refAbstract=null), Reference(id=1330183708298031878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=MURAMATSU H, LAM K, BAJUSZ C, et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated nucleoside-modified mRNA vaccine[J]. Mol Ther, 2022, 30(5): 1941-1951., articleTitle=null, refAbstract=null), Reference(id=1330183708398695175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=KLIMEK L, NOVAK N, CABANILLAS B, et al. Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation [J]. Allergy, 2021,76(11): 3307-3313., articleTitle=null, refAbstract=null), Reference(id=1330183708495164168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=NDEUPEN S, QIN Z, JACOBSEN S, et al. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory [J]. iScience, 2021, 24(12): 103479., articleTitle=null, refAbstract=null), Reference(id=1330183708558078729, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG L G, RICHARDS A, BARRASA M I, et al. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues [J]. Proc Natl Acad Sci U S A, 2021,118(21): e2105968118., articleTitle=null, refAbstract=null), Reference(id=1330183708629381900, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=ALDÉN M, FALLA F O, YANG D W, et al. Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line [J]. Curr Issues Mol Biol, 2022, 44(3): 1115-1126., articleTitle=null, refAbstract=null), Reference(id=1330183708704879373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=QIN M, DU G S, SUN X. Recent advances in the noninvasive delivery of mRNA [J]. Acc Chem Res, 2021,54(23): 4262-4271., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330183699863286456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=1., ext=[AuthorCompanyExt(id=1330183699867480761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330183699880063674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)]), AuthorCompany(id=1330183699947172539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=2., ext=[AuthorCompanyExt(id=1330183699955561148, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330183699963949757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.03.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.03.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.03.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.03.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1678377600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
mRNA疫苗核酸修饰与递送系统的发展历程与挑战
董文彬 1 , 张雪梅 1, * , 陈一飞 2, *
中国医药工业杂志 | 综述 2023,54(3): 304-311
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (3) : 304 -311
mRNA疫苗核酸修饰与递送系统的发展历程与挑战
全屏
[Author(id=1330183700047835839, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330183700131721921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700047835839, language=EN, stringName=Wenbin DONG, firstName=Wenbin, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183700215608002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700047835839, language=CN, stringName=董文彬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学药学院,上海 201203, bio={"content":"

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

"}, bioImg=null, bioContent=

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699863286456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=1., ext=[AuthorCompanyExt(id=1330183699867480761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330183699880063674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1330183700303688388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xuemzhang@fudan.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183700391768774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700303688388, language=EN, stringName=Xuemei ZHANG, firstName=Xuemei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183702010770123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183700303688388, language=CN, stringName=张雪梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699863286456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=1., ext=[AuthorCompanyExt(id=1330183699867480761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330183699880063674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699863286456, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])]), Author(id=1330183702128210637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenyifei25@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330183702233068239, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183702128210637, language=EN, stringName=Yifei CHEN, firstName=Yifei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330183702325342928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, authorId=1330183702128210637, language=CN, stringName=陈一飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330183699947172539, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, xref=2., ext=[AuthorCompanyExt(id=1330183699955561148, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330183699963949757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330183699066368692, companyId=1330183699947172539, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])])]
董文彬1, 张雪梅1, * , 陈一飞2, *
作者信息
  • 1.复旦大学药学院,上海 201203
  • 2.上海药品审评核查中心,上海 201203
通讯作者:
陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学研究。E-mail:
张雪梅(1971—),女,教授,从事药学、药理学相关研究。E-mail:
作者简介:

董文彬(1997—),女,硕士研究生,研究方向:新药研究与开发。

Development and Challenges for Nucleic Acid Modifications and Delivery Systems of mRNA Vaccines
Wenbin DONG1, Xuemei ZHANG1, * , Yifei CHEN2, *
Affiliations
  • 1.School of Pharmacy, Fudan University, Shanghai 201203
  • 2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
出版时间: 2023-03-10 doi: 10.16522/j.cnki.cjph.2023.03.002
文章导航
收藏切换

mRNA疫苗因其开发灵活性、高免疫原性而受到学术界、产业界和监管方等的广泛关注,在2019新型冠状病毒病(corona virus disease 2019,COVID-19)的疫情防控中得到了广泛应用。mRNA疫苗的基因重组风险低、安全性好,但稳定性较差,贮存和运输较困难。可采用核酸修饰和新型递送系统以改善mRNA疫苗的稳定性,增强其安全性和有效性。该文从mRNA疫苗的分子学基础与制剂开发角度,介绍了mRNA疫苗的发展现状及其关键技术,并讨论了mRNA疫苗在研发和应用中的难点和可能的解决方向。

mRNA疫苗  /  核酸修饰  /  递送系统

mRNA vaccines have attracted extensive attention from academia, industry, and regulatory agencies for their development flexibility and high immunogenicity. They have been widely used to prevent and control the Corona Virus Disease 2019(COVID-19). While mRNA vaccines have a low risk of recombination and good safety, their poor stability and strict storage and transportation conditions limit their applications. Nucleic acid modifications and novel delivery systems have been used to improve the stability of mRNA vaccines and enhance their safety and efficacy. From the perspective of the molecular basis and formulation development of mRNA vaccines, the development status and critical technologies of mRNA vaccines are reviewed, and the challenges and possible solutions of mRNA vaccines in the development and application are discussed.

mRNA vaccine  /  nucleic acid modification  /  delivery system
董文彬, 张雪梅, 陈一飞. mRNA疫苗核酸修饰与递送系统的发展历程与挑战. 中国医药工业杂志, 2023 , 54 (3) : 304 -311 . DOI: 10.16522/j.cnki.cjph.2023.03.002
Wenbin DONG, Xuemei ZHANG, Yifei CHEN. Development and Challenges for Nucleic Acid Modifications and Delivery Systems of mRNA Vaccines[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (3) : 304 -311 . DOI: 10.16522/j.cnki.cjph.2023.03.002

参考文献 引证文献
排序方式:
[1]
CREECH C B, WALKER S C, SAMUELS R J. SARS-CoV-2 Vaccines [J]. JAMA, 2021, 325(13): 1318-1320.
[2]
杭辰悦,徐山杉,吴其峰,等.mRNA 治疗及其应用前景[J].科学通报,2021,66(Z2):3649-3666.
[3]
GHATTAS M, DWIVEDI G, LAVERTU M, et al. Vaccine technologies and platforms for infectious diseases:current progress, challenges, and opportunities [J]. Vaccines(Basel), 2021, 9(12): 1490.
[4]
叶瑞贤,张锡宝.疫苗的发展历史[J].皮肤科学通报,2020,37(4):329-335.
[5]
KIM J, EYGERIS Y, GUPTA M, SAHAY G, et al. Self-assembled mRNA vaccines [J]. Adv Drug Deliv Rev, 2021,170: 83-112.
[6]
MINNAERT A K, VANLUCHENE H, VERBEKE R, et al. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across [J]. Adv Drug Deliv Rev, 2021, 176:113900.
[7]
LI C, LEE A, GRIGORYAN L, et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine [J]. Nat Immunol, 2022, 23(4): 543-555.
[8]
井汇源,段二珍,董望.体外转录的自我复制型mRNA疫苗研究进展[J].中国生物工程杂志,2020,40(12):25-30.
[9]
BEISSERT T, PERKOVIC M, VOGEL A, et al. A trans-amplifying RNA vaccine strategy for induction of potent protective immunity [J]. Mol Ther, 2020, 28(1): 119-128.
[10]
CHAUDHARY N, WEISSMAN D, WHITEHEAD K A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation [J]. Nat Rev Drug Discov, 2021,20(11): 817-838.
[11]
WANG Y, ZHANG Z Q, LUO J W, et al. mRNA vaccine:a potential therapeutic strategy [J]. Mol Cancer, 2021,20(1): 33.
[12]
LINARES-FERNÁNDEZ S, LACROIX C, EXPOSITO J Y, et al. Tailoring mRNA vaccine to balance innate/adaptive immune response [J]. Trends Mol Med, 2020, 26(3): 311-323.
[13]
DOLGIN E. The tangled history of mRNA vaccines [J]. Nature, 2021, 597(7876): 318-324.
[14]
KRIEG P A, MELTON D A. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs[J]. Nucleic Acids Res, 1984, 12(18): 7057-7070.
[15]
JIRIKOWSKI G F, SANNA P P, MACIEJEWSKI-LENOIR D, et al. Reversal of diabetes insipidus in Brattleboro rats:intrahypothalamic injection of vasopressin mRNA [J]. Science, 1992, 255(5047): 996-998.
[16]
KARIKÓ K, BUCKSTEIN M, NI H, et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA[J]. Immunity, 2005, 23(2): 165-175.
[17]
JIA L F, QIAN S B. Therapeutic mRNA engineering from head to tail [J]. Acc Chem Res, 2021, 54(23): 4272-4282.
[18]
田颖,张娜娜,秦成峰,等.mRNA技术应对病毒传染病的研究进展[J].微生物学通报,2022,49(7):2849-2861.
[19]
WALCZAK S, NOWICKA A, KUBACKA D, et al. A novel route for preparing 5' cap mimics and capped RNAs:phosphate-modified cap analogues obtained via click chemistry [J]. Chem Sci, 2017, 8(1): 260-267.
[20]
PASSMORE L A, COLLER J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression [J]. Nat Rev Mol Cell Biol, 2022, 23(2): 93-106.
[21]
LIMA S A, CHIPMAN L B, NICHOLSON A L, et al. Short poly(A) tails are a conserved feature of highly expressed genes [J]. Nat Struct Mol Biol, 2017, 24(12): 1057-1063.
[22]
LEPPEK K, DAS R, BARNA M. Functional 5' UTR mRNA structures in eukaryotic translation regulation and how to find them [J]. Nat Rev Mol Cell Biol, 2018, 19(3): 158-174.
[23]
MAYR C. Regulation by 3'-untranslated regions [J]. Annu Rev Genet, 2017, 51: 171-194.
[24]
JEFFS L B, PALMER L R, AMBEGIA E G, et al. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA [J]. Pharm Res, 2005,22(3): 362-372.
[25]
GEALL A J, VERMA A, OTTEN G R, et al. Nonviral delivery of self-amplifying RNA vaccines [J]. Proc Natl Acad Sci U S A, 2012, 109(36): 14604-14609.
[26]
CULLIS P R, HOPE M J. Lipid nanoparticle systems for enabling gene therapies [J]. Mol Ther, 2017, 25(7): 1467-1475.
[27]
JARZEBSKA N T, MELLETT M, FREI J, et al. Protamine-based strategies for RNA transfection [J]. Pharmaceutics,2021, 13(6): 877.
[28]
KREMSNER P G, AHUAD GUERRERO R A, ARANA-ARRI E, et al. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America(HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial [J]. Lancet Infect Dis, 2022, 22(3): 329-340.
[29]
KOWALSKI P S, RUDRA A, MIAO L, et al. Delivering the messenger: advances in technologies for therapeutic mRNA delivery [J]. Mol Ther, 2019, 27(4): 710-728.
[30]
REN J, CAO Y M, LI L, et al. Self-assembled polymeric micelle as a novel mRNA delivery carrier [J]. J Control Release, 2021, 338: 537-547.
[31]
SAMARIDOU E, HEYES J, LUTWYCHE P. Lipid nanoparticles for nucleic acid delivery: current perspectives[J]. Adv Drug Deliv Rev, 2020, 154-155: 37-63.
[32]
RUSESKA I, FRESACHER K, PETSCHACHER C, et al. Use of protamine in nanopharmaceuticals-a review [J]. Nanomaterials(Basel), 2021, 11(6): 1508.
[33]
PUTNAM D. Polymers for gene delivery across length scales [J]. Nat Mater, 2006, 5(6): 439-451.
[34]
PARHIZ H, BRENNER J S, PATEL P N, et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation(IE)[J]. J Control Release,2022, 344: 50-61.
[35]
MU X, HUR S. Immunogenicity of in vitro-transcribed RNA [J]. Acc Chem Res, 2021, 54(21): 4012-4023.
[36]
ZHONG Z F, MCCAFFERTY S, OPSOMER L, et al. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs [J]. Mol Ther, 2021, 29(4): 1370-1381.
[37]
BAIERSDÖRFER M, BOROS G, MURAMATSU H, et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA [J]. Mol Ther Nucleic Acids,2019, 15: 26-35.
[38]
WU M Z, ASAHARA H, TZERTZINIS G, et al. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription [J]. RNA, 2020, 26(3): 345-360.
[39]
ZHAO H, WANG T C, LI X F, et al. Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates [J]. Signal Transduct Target Ther, 2021, 6(1): 438.
[40]
STITZ L, VOGEL A, SCHNEE M, et al. A thermostable messenger RNA based vaccine against rabies [J]. PLoS Negl Trop Dis, 2017, 11(12): e0006108.
[41]
MURAMATSU H, LAM K, BAJUSZ C, et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated nucleoside-modified mRNA vaccine[J]. Mol Ther, 2022, 30(5): 1941-1951.
[42]
KLIMEK L, NOVAK N, CABANILLAS B, et al. Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation [J]. Allergy, 2021,76(11): 3307-3313.
[43]
NDEUPEN S, QIN Z, JACOBSEN S, et al. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory [J]. iScience, 2021, 24(12): 103479.
[44]
ZHANG L G, RICHARDS A, BARRASA M I, et al. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues [J]. Proc Natl Acad Sci U S A, 2021,118(21): e2105968118.
[45]
ALDÉN M, FALLA F O, YANG D W, et al. Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line [J]. Curr Issues Mol Biol, 2022, 44(3): 1115-1126.
[46]
QIN M, DU G S, SUN X. Recent advances in the noninvasive delivery of mRNA [J]. Acc Chem Res, 2021,54(23): 4262-4271.
2023年第54卷第3期
18
3
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.03.002
  • 接收时间:2022-08-10
  • 首发时间:2026-11-19
  • 出版时间:2023-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-08-10
基金
作者信息
    1.复旦大学药学院,上海 201203
    2.上海药品审评核查中心,上海 201203

通讯作者:

陈一飞(1983—),女,副研究员,从事GCP/GLP、药品监管科学研究。E-mail:
张雪梅(1971—),女,教授,从事药学、药理学相关研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.03.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏